炎症
槲皮素
纤维化
肌成纤维细胞
癌症研究
分泌物
体内
药理学
细胞
医学
免疫学
离体
T细胞
化学
间充质干细胞
细胞培养
细胞生长
全身给药
信号转导
p38丝裂原活化蛋白激酶
NFKB1型
细胞信号
全身炎症
药品
受体
多发性硬化
作者
Xiangzhen Kong,Hiochon Leong,Min Du,Jingyi Yang,Jingzhen Lai,Ziying Dong,Menghua Hu,Yifei Gu,Yexin Li,Qiaorui Tan,Haiyan Chu,Qingmei Liu,Y X Ma,Weihong Xu,Shanji Li,Yi Chen,Dongdong Chen,Yi Chen,Wei Lu,Jie Zhu
标识
DOI:10.3389/fimmu.2026.1863530
摘要
Background Aberrant Th17 cell activation and interleukin-17 (IL-17) production drive skin inflammation and progressive fibrosis in systemic sclerosis (SSc). Identifying small molecules that can precisely modulate these pathogenic T cell responses is crucial for developing novel SSc therapies. Methods We utilized primary CD4 + T cells isolated from SSc patients and a bleomycin-induced SSc mouse model to evaluate the immunomodulatory effects of quercetin. Direct molecular target engagement was rigorously validated using Drug Affinity Responsive Target Stability (DARTS) and Cellular Thermal Shift Assay (CETSA). Results In patient-derived CD4 + T cells, quercetin treatment significantly suppressed the secretion of pro-inflammatory cytokines, including IL-17A and IFN-γ. Mechanistically, we demonstrated through DARTS and CETSA that quercetin directly binds to and stabilizes transcription factors RELA (p65) and c-Jun. This interaction effectively inhibited their phosphorylation and subsequent nuclear translocation, thereby dampening the IL-17 signaling cascade. In vivo , oral administration of quercetin significantly attenuated skin thickness, collagen deposition, and myofibroblast activation in SSc mice. Conclusion Our findings identify the RELA/c-Jun axis as a critical target for modulating T cell pathogenicity in SSc and suggest that quercetin holds therapeutic potential as an immunometabolic modulator to alleviate skin fibrosis.
科研通智能强力驱动
Strongly Powered by AbleSci AI